Why is Aarti Drugs falling/rising?

As of 07-Jul, Aarti Drugs Ltd's stock price is rising, currently at Rs 491.00, reflecting an increase of Rs 3.45 or 0.71%. The stock has shown strong performance recently, gaining 10.23% over the last seven days and outperforming its sector by 0.79% today. It has also been trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend. Additionally, the stock has seen increased investor participation, with delivery volume rising by 19.98% against the 5-day average. Despite a one-year return of -11.39%, the company has demonstrated high management efficiency with a return on capital employed (ROCE) of 17.84% and a strong ability to service its debt, which may contribute to investor confidence.
In the broader market context, Aarti Drugs has outperformed the Sensex in the short term, with a 1-week return of +7.11% compared to the benchmark's -0.20%. However, the stock has consistently underperformed against the benchmark over the last three years, which raises concerns about its long-term growth potential. While institutional investors have increased their stake, indicating a level of confidence in the company's fundamentals, the stock's historical performance and slower growth rates in net sales and operating profit over the past five years could pose risks for future performance.